NEOGEN CORP MI false 0000711377 0000711377 2020-02-06 2020-02-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 6, 2020

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

MICHIGAN

 

0-17988

 

38-2367843

620 Lesher Place Lansing, Michigan

48912

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code 517-372-9200

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

            

 

N/A

 

        

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 6, 2020 Thomas H. Reed informed the Board of Directors of the Company that he was resigning from the Board, effective immediately.

Mr. Reed, 74, has been a member of the Board of Directors since 1995 and is resigning for personal reasons. The Company advises that the Board of Directors expects to present a nominee to succeed Mr. Reed on the Board; this nominee is expected to be included in the Company’s proxy statement, which is scheduled to be mailed to shareholders at the end of August 2020.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

None


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

NEOGEN CORPORATION

 

 

(Registrant)

         

Date: February 12, 2020

 

 

 

 

/s/ Steven J. Quinlan

 

 

Steven J. Quinlan

 

 

Vice President & CFO